Company: MGLD
Filing Date: 2025-03-07
Form Type: 424B5
Source: 0001493152-25-009595
Chunk: 16

Company: Marygold Companies, Inc.
Filing Date: 2025-03-07
Form: 424B5
Chunk 16
---
 bylaws and applicable provisions of Nevada law. You should read our amended and restated articles of incorporation, as amended, and our amended and restated bylaws for a more detailed description of our securities.

Holders

As of March 5, 2025, we had 362 holders of record of our common stock. The number of holders of record does not include certain beneficial owners of our common stock, whose shares are held in the names of various dealers, clearing agencies, banks, brokers and other fiduciaries.

Options and Restricted Stock

As of December 31, 2024, the following stock options and shares of restricted stock have been issued and are outstanding pursuant to our 2021 Omnibus Equity Incentive Plan:

| ● | 640,881                                                                                                                                   
 options to purchase our common stock at a weighted average exercise price of $1.35 per share of which 209,445 are vested and exercisable, 
 and                                                                                                                                       |
| ● | 370,584                                                                                                                                   
 shares of restricted stock pursuant to restricted stock grants                                                                            |

| S-14 |

Transfer Agent and Registrar

The transfer agent and registrar for our common stock is Issuer Direct Corporation, 500 Perimeter Park Drive, Morrisville, North Carolina 27560; telephone number: 877.481.4014.

Stock Exchange Listing

Our common stock is listed on the NYSE American under the symbol “MGLD”.

<div align='center'>PLAN OF DISTRIBUTION</div>

On March 7, 2025, we entered into the Equity Distribution Agreement with Maxim pursuant to which we may issue and sell shares of our common stock, from time to time, through or to Maxim, acting as our agent or as principal, with an aggregate market value of up to $4,650,000. Sales of our common stock, if any, will be made at market prices by any method that is deemed to be an “at the market offering”of equity securities as defined in Rule 415(a)(4) under the Securities Act, including sales made directly on the NYSE American or any other existing trading market in the United States for our common stock, sales made to or through a market maker other than on an exchange or otherwise, directly to Maxim as principal, in negotiated transactions at market prices prevailing at the time of sale or at prices related to such prevailing market prices and/or in any other method permitted by law. The Equity Distribution Agreement will be filed as an exhibit to a Current Report on Form 8-K